Skip to main content
Nucleic Acids Research logoLink to Nucleic Acids Research
. 2021 Dec 14;50(6):e31. doi: 10.1093/nar/gkab1212

A simple and general approach to generate photoactivatable DNA processing enzymes

Merve-Zeynep Kesici 1, Philip Tinnefeld 2,, Andrés Manuel Vera 3,
PMCID: PMC8989547  PMID: 34904657

Abstract

DNA processing enzymes, such as DNA polymerases and endonucleases, have found many applications in biotechnology, molecular diagnostics, and synthetic biology, among others. The development of enzymes with controllable activity, such as hot-start or light-activatable versions, has boosted their applications and improved the sensitivity and specificity of the existing ones. However, current approaches to produce controllable enzymes are experimentally demanding to develop and case-specific. Here, we introduce a simple and general method to design light-start DNA processing enzymes. In order to prove its versatility, we applied our method to three DNA polymerases commonly used in biotechnology, including the Phi29 (mesophilic), Taq, and Pfu polymerases, and one restriction enzyme. Light-start enzymes showed suppressed polymerase, exonuclease, and endonuclease activity until they were re-activated by an UV pulse. Finally, we applied our enzymes to common molecular biology assays and showed comparable performance to commercial hot-start enzymes.

INTRODUCTION

DNA processing enzymes, such as DNA polymerases, nucleases and ligases, have been extremely useful tools in biotechnology, molecular biology, genetic engineering, molecular diagnostics methods and synthetic biology approaches (1–6). Over the last years, the development of enzymes with controllable activity has drawn attention as it allows minimizing secondary effects of undesired activity and triggering specific processes at will (7–11). One classical example is the development of hot-start PCR approaches (9,11–16). DNA polymerases are arguably one of the most successful applications of enzymes to biotechnology with applications in molecular biology, genome sequencing, sensing and diagnostics among others (5,17). Yet, a common practical problem of these assays is that significant polymerase or proofreading activities (3′ to 5′ exonuclease activity) of the DNA polymerase during sample preparation can lead to loss of product yield and lowered sensitivity and specificity (9–11,14,18,19). Polymerase activity can elongate misprimed events, including primer dimers and unspecific off-target binding events, resulting in by-products that can compete with the desired amplicon. Degradation of the 3′-terminal nucleotides of the primer by 3′ to 5′ exonuclease activity can enhance off-target binding also inducing mispriming. Furthermore, exonucleolitic degradation of primers and template decrease the overall product yield (9–11,13,14,18,19). Hot-start approaches deal with these problems by blocking the reaction till the mixture reaches an elevated hot-start temperature (9,11,13,16,20).

Another common strategy has been the design of photoactivatable enzymes, which has the additional advantage of allowing both space and time-controlled enzymatic activity. Light-controlled PCR, DNA recombination, and the development of genetic switches have been possible thanks to photoactivatable enzyme versions (7,8,12,21). Site-specific endonucleases, such as Cas9, homing endonucleases, zinc finger nucleases, and restriction endonucleases are being used for genome editing. The development of photoactivatable site-specific endonucleases has focussed on reducing the off-site cleavage that these enzymes exhibit over time and in providing spatial and time-controlled genome engineering (7,22–26). Furthermore, light-controlled specific endonuclease could be used to elicit specific responses or conformational changes in DNA origami structures (27,28).

The common drawback of all of these strategies is that they are not easily generalizable. Most common hot-start strategies employ specific aptamers or antibodies to selectively block the DNA polymerases. The development of such aptamers and antibodies require time-consuming screening of libraries and laborious optimization steps and, after all, they are specific for a certain polymerase (9,15,16,20). Besides, the unavoidable heating step makes this type of strategy non-viable for mesophilic DNA polymerases, such as the Phi29 DNA polymerase (Phi29 pol), which is used for whole-genome amplification and sensing applications (5,29–31). The production of photoactivatable enzymes is commonly based on the incorporation of photosensitive unnatural amino acids and requires detailed structural and mechanistic information of the enzyme (7,12,21,22,32). A meticulous study of the case is necessary to place the photosensitive residue in a position that blocks the activity in the off state and release it only after photoactivation. The latter requires robust knowledge of the enzyme and devising a suitable strategy can be very challenging. Overall, these problems call for strategies of broader application and easier implementation to control the enzymatic activity of DNA processing enzymes. Here we present a quite general method to produce photoactivatable enzymes. We show the successful development of three light-activatable DNA polymerases and one nuclease, and prove their applicability to classical molecular biology methods.

MATERIALS AND METHODS

Construct design and molecular cloning

The binding of the ssDNA to the enzymes was achieved by site-specific incorporation of the unnatural amino acid 4-azido-l-phenylalanine (azPhenylalanine). Using the amber codon suppression (TGA) strategy (33), this unnatural amino acid was included in the sequence serine-glycine-azPhenylalanine-glycine-serine, which was added at the C-terminus of the enzyme. The SG-GS stretch provides conformational flexibility and accessibility, and site-specific labeling can be achieved without compromising any of the native residues of the enzymes. As we initially intended to use the enzyme attached to DNA nanostructures, a mutant with reduced exonuclease activity was used in the case of the Phi29 polymerase (N62D (34)). For the three DNA polymerases (N62D Phi29 pol (34), Pfu Pol and Taq pol) and the StuI restriction enzyme, codon-optimized genes for expression in Escherichia coli were designed using a web server (http://genomes.urv.es/OPTIMIZER/) and synthetic genes were purchased from Eurofins Genomics (Germany). The Pfu Pol, Taq pol and StuI genes were subcloned for expression in the pET24-d plasmid (Novagen, Merck Millipore, Germany) using its NcoI and XhoI restriction sites. The Phi29 pol gene was subcloned into pET21-a (Novagen) between the NdeI and XhoI sites. Standard protocols for molecular cloning were used (6) and the E. coli strain XL1blue was used for all cloning steps. Enzymes for cloning were purchased from New England Biolabs (MA, USA). The amino acid sequence of the proteins can be found in the Protein sequence section of the Supporting Material

Protein production and purification

The Escherichia coli BL21 Star (DE3) strain transformed with the plasmid pEVOL-pAzF (a gift from Prof. Peter Schultz, Addgene plasmid #31186) was used for protein expression. pEVOL-pAzF E. coli cells co-transformed with the expression plasmids were grown with vigorous shaking at 37°C in LB medium with the adequate antibiotics until they reached an OD600 of ≈1. After that, the cells were pelleted, washed with M9 minimal medium, and resuspended in M9 minimal medium supplemented with 0.2 mg/mL 4-azido-l-phenylalanine (Hycultec GmbH, Germany), 0.02% arabinose, and antibiotics. The culture was incubated at 37°C for one hour and finally induced with 1 mM IPTG overnight at 16°C. Cells were lysed and purified by nickel affinity chromatography as described elsewhere (35). In the case of Taq and Pfu pol samples, the lysate was heated to 75°C for 20 min after lysis to yield samples free of DNA contamination from E. coli. Phi29 pol, Pfu pol, and StuI were further purified by cationic exchange in a HiScreen HP SP column (GE Healthcare), and Taq pol by anionic exchange in a HiScreen Q SP column (GE Healthcare). StuI was further purified by hydrophobic interaction chromatography in a HiTrap Phenyl HP column (GE Healthcare). The ion-exchange chromatography was performed as a linear gradient from 20 mM Tris, 100 mM NaCl, 0.2 mM EDTA pH 7.4 buffer to 20 mM Tris, 1 M NaCl, 0.2 mM EDTA. The purity of the proteins was higher than 95% as assessed by Coomassie staining in SDS-PAGE gels, except for StuI. The concentration was estimated spectrophotometrically using the theoretical extinction coefficient at 280 nm.

Protein–oligo coupling

All oligonucleotides were purchased from Biomers GmbH (Germany). Two different types of photocleavable linkers, PC linker (1-(2-nitrophenyl)-1,3-propanediol, https://www.biomers.net/en/Catalog/Modifications/PCLin/INTMOD) and PC BMN linker (1-(2-nitrophenyl)-1,4-butanediol, https://www.biomers.net/en/Catalog/Modifications/PCLBM/INTMOD) were used, both yielding efficient cleaving. For simplicity, we use the term ‘PC linker’ to refer to both types of photocleavable linkers, details on the specific photocleavable linker used are found in Supplementary Table S1. In order to prevent the degradation of the oligonucleotides by the exonuclease activity of the polymerases, the DBCO group was included in the 3′-end in the case of Phi29 and Pfu pol (3′-5′ exo activity) and in the 5′ end for Taq pol (5′-3′ exo activity). The DBCO group was included in the 3′ end in the case of StuI. The PC linker was included before the terminal nucleotide bearing the DBCO site. Supplementary Table S1 summarizes the details of the DBCO-modified oligos and the enzymes to which they were attached. For oligo-labeling, the proteins were incubated for at least 3 h with the DBCO-modified oligos at a molar ratio of 1:1.3 or 1:1.5 in light-tight tubes at room temperature. Afterwards, the samples were purified by ionic exchange, using a cationic exchange column followed by an anionic exchange column. The different charges of free polymerases, polymerase-ssDNA, and free oligos allowed for efficient separation with this purification scheme. In the case of StuI, some residual free protein co-eluted always with the StuI-ssDNA, even after including an extra hydrophobic interaction chromatography step (see Supplementary Figure S3 and discussion there). The Phi29 pol, Taq pol and StuI samples were stored in 10 mM Tris–HCl, 100 mM KCl, 0.1 mM EDTA, 1 mM DTT, 0.5% Tween-20, 0.5% IGEPAL CA-630 and 50% glycerol. Pfu pol samples were stored in 25 mM Tris, 0.1 mM EDTA, 1 mM DTT, 0.5% Tween-20, 0.5% IGEPAL CA-630 and 50% glycerol. All enzymes were stored at –20°C.

Determination of the concentration of the enzyme–oligo constructs

We estimated the concentration of the DNA Polymerase-oligo samples building calibration curves. For each polymerase-oligo construct, the unmodified polymerase was mixed with the respective DBCO oligo at a molar ratio of 1:1, and the absorbance at 260 and 280 nm was measured for several dilutions of this sample. As the concentration of the polymerase in the sample was known, we performed a linear fit of absorbance vs enzyme concentration. Then, the absorbance at 260 and 280 nm of the polymerase-oligo samples were used to interpolate their concentration using the linear fits. Finally, the mean value of the estimated concentration at 260 and 280 nm was used as the sample concentration. For StuI-PC_oligo, the concentration was estimated using the theoretical absorption coefficient of the oligo at 260 nm.

Light activation

The UV pulses were applied using either a 45-W 315 nm UV-Pad (Vilber, France) or a handheld 6-W 365 nm lamp (Analytikjena GmbH, Germany). The samples were irradiated just before the polymerization or digestion reaction was started.

Multiply-primed amplification experiments

We used multiply-primed amplification (18) to test the activity of the Phi29 pol samples. T7 blue plasmid (Novagen, Merck Millipore) and human genomic DNA (Roche Diagnostics, Germany) were used as templates for the experiments in Figure 2 and Supplementary Figure S1a, and Figure 5A and Supplementary Figure S1b respectively. Random hexamers (Thermofisher Scientific, USA) and the template were heated up at 95°C for 3 min and incubated afterwards for 5 min on ice for annealing. Reactions took place at 30°C in 50 mM Tris–HCl, 10 mM MgCl2, 10 mM (NH4)2SO4, 4 mM DTT, 0.02% Tween20, 0.2 mg/ml BSA pH 7.5, supplemented with 0.5 mM dNTPs. Exonuclease-protected hexamers (50 μM) were used for the plasmid amplification experiments and unprotected hexamers (6.25 μM) for the failure-by-design ones. Template concentration was kept at 0.3 ng/μl in both cases. The enzymes were heat-inactivated for 15 min at 65°C at the end of the experiments. To facilitate visualization of the reaction, the T7 blue amplified plasmid was digested with BamHI to linearize the concatenated plasmid copies. Quantification of the enzymatic activity (Figure 2D and E) was done using the fluorescence emission of SYBR I nucleic acid stain (Thermofisher Scientific). SYBR I was added to the samples after the reaction was completed and the fluorescence measured in a real-time PCR machine (Rotor-Gene Q, Qiagen, USA). Triplicates for each condition were measured and the mean value was calculated. The fluorescence intensities were normalized to the higher fluorescence signal (the most active sample).

Figure 2.

Figure 2.

Light-activation of Phi29 DNA pol. (A) SDS-Page showing the cleavage of the PC oligo from the Phi29 pol-PC_oligo construct by 315 nm UV light. Light pulses of increasing duration (5, 10 and 20 s, lanes 2–5) produced a progressive fading of the Phi29 pol-PC_oligo band (lane 2 for comparison) correlated with the appearance and enrichment of the free enzyme band (lane 1 for comparison). (B) Activity test in light-activated Phi29 pol-PC_oligo samples. Phi29 pol-PC_oligo samples illuminated with 315 nm UV pulses of increasing intensity (1 s at 70% of lamp intensity in lane 5, and 1s normal lamp intensity in lane 6) and duration (1, 2 and 10 s, for lanes 6, 7 and 8, respectively) displayed amplified product of growing intensity. Activity was not observed in non-irradiated (lane 4) and Phi29 pol-oligo samples (lanes 2 and 3, 10 s 315 nm UV pulse was used for lane 3). (C) Similar light-activated behaviour was observed with 365 nm UV light (from lanes 3 to 8, light pulses of 5, 10, 20, 30 and 60 s, respectively). For comparison, a sample illumined 10 s with 315 nm UV is included in lane 2. (D) Effect of UV light in the assay. The unmodified enzyme was irradiated with 315 nm and 365 nm UV for 10 s and 120 s respectively. Non-illumined and irradiated Phi29 pol-PC_oligo samples (120 s 365 nm UV) are shown for comparison. (E) Light activation curve of Phi29 pol-PC_oligo samples (365 nm UV). The signal in the non-illuminated samples (0 s) corresponds to fluorescence background, as it is not statistically different (P < 0.01) to inactive samples (no dNTPS). (F) Light activation of Phi29 pol-PC_oligoScr (lanes 1 and 2) and Phi29 pol_PC-oligo2 constructs (lanes 3 and 4). A light pulse of 365 nm 120 s was applied (lanes 2 and 4). All activity assays were performed with 20 nM enzyme for 2 h at 30°C. Phi29 pol is represented in blue and Phi29 pol-PC_Oligo in pale blue.

Figure 5.

Figure 5.

Light-start applications. (A–C) failure-by-design experiments for Phi29 pol-PC_oligo, Pfu pol-PC_oligo, and Taq pol-PC_oligo, respectively. (A) Whole-genome amplification of human DNA by Phi29 pol-PC_oligo, and (B) PCR amplification of E. coli bir A gene by Pfu pol-PC_oligo. The samples that were kept inactive during the pre-incubation step showed an increased yield of amplified products (lane 1), consistent with reduced exonuclease degradation of the primers. (C) Light-start PCR shows protection against the formation of primer-dimers (lane 4 versus lane 5, see lane 1 for dimers reference) similar to that achieved by commercial hot-start Taq pol enzymes (lanes 2 and 3, NE Biolabs aptamer-based hot-start and standard Taq pol). Lane 1 shows a PCR performed without DNA template as a reference for primer dimers formation. Enzymes concentrations were 120, 7.5 and 50 nM for Phi29, Pfu and Taq samples. See Supplementary Figure S1 for additional independent experiments.

PCR experiments

PCRs were carried out in 50 mM Tris–HCl, 10 mM KCl, 10 mM (NH4)2SO4, 2 mM MgSO4, 0.1% Triton® X-100, 0.1 mg/ml BSA pH 10.2 in a volume of 25 μl. As templates, 0.25 ng of a plasmid carrying a codon-optimized version of the human cyclophilin A gene (PCRs in Figure 3bB) and E. coli genomic DNA were used (PCRs in Figure 5B, C, Supplementary Figure S1c, and S1d). E. coli genomic material was prepared from 5 ml overnight culture of XL1blue cells. The cells were pelleted, washed out twice with water, and resuspended in 200 μl of molecular biology grade water. Finally, they were heated at 99°C for 5 min, centrifuged for 2 min at 15 000 g, and the supernatant with the chromosomal DNA was transferred to a fresh tube. This chromosomal sample was diluted 10 times and 0.5 μl was used for the PCRs. Cycling parameter and primer sequences can be found in Supplementary Tables S2 and S3 respectively.

Figure 3.

Figure 3.

Polymerase and nuclease activity of different polymerases can be blocked. (A) 3′ to 5′ exo activity of Phi29 pol-PC_oligo. Only light-activated samples (lane 4 and 5, 2 s and 10 s 315 nm pulses, respectively) recovered the exonuclease activity of the unmodified Phi29 pol (lane 2). (B) PCR with Taq pol-PC_oligo (left gel) and Pfu pol-PC_oligo (right gel) samples. In both cases, PCR product was not detected in non-illuminated samples (lane 2). Only irradiated samples (lane 3) showed the PCR product present in the unmodified enzyme samples (lane 1). 20 nM of Taq pol and 15 nM Pfu pol were used. (C and D) Nuclease activity assays for Taq-PC_oligo and Pfu-PC_oligo. The exonucleolitic pattern of unmodified enzymes (lane1) was only recovered in light-activated samples (see lane 3 versus non-illuminated ones on lane 4). Left and right gel in (C) show 3′ to 5′ exo and proofreading activities for Pfu pol-PC_oligo respectively. Gel in (D) shows 5′ flap activity test for Taq-PC_oligo. Phi 29, Taq and Pfu pol are depicted in blue, brown, and yellow respectively, and the oligo-modified versions in the corresponding pale colors. A 10 s, 315 nm UV pulse was used for the experiments in (B–D).

Nuclease activity test

The test on 3′ to 5′ exonuclease activity of Phi29 samples were conducted using a 5′ FAM-labeled ssDNA oligonucleotide (FAM exo 3′ activity ssDNA, see Supplementary Table S4). 10 nM of enzyme was incubated with 50 nM ssDNA substrate for 10 min at 30°C in 50 mM Tris–HCl, 10 mM MgCl2, 10 mM (NH4)2SO4, 4 mM DTT, 0.02% Tween20, 0.2 mg/ml BSA pH 7.5. Exonuclease tests for Pfu samples were performed likewise but in 20 mM Tris–HCl, 10 mM KCl, 10 mM (NH4)2SO4, 2 mM MgSO4, 0.1% Triton® X-100 and 0.1 mg/ml BSA pH 8.8 at 45°C for 10 min. The 3′ to 5′ exonuclease proofreading activity of Pfu was probed using a dye-labeled dsDNA with a five bases mismatch at the 3′ end of the labeled oligonucleotide (FAM exo 3′ reverse + Exo 3′ mismatch forward, see Supplementary Table S4). The dye-labeled dsDNA was annealed forehand using a temperature gradient, and the reaction took place using 5 nM of enzyme and 50 nM of dsDNA at 45°C for 1 min. The cleavage of single-stranded arms at the bifurcated end of base-paired duplexes by Taq pol (5′flap endonuclease activity) was used to test the nuclease activity of the enzyme (36). A bifurcated junction was used as substrate, and a primer located 4 bases upstream of the bifurcation point was included as it is known to promote the nuclease activity (36). The oligonucleotide forming the 5′ protruding strand was labeled at its 3′ end with FAM and the fork-like structure assembled in a temperature gradient (Exo 5′ taq fork FAM + Exo 5′ taq template + Exo 5′ taq 4pb gap, see Supplementary Table S4). The reactions took place for 20 min at 45°C using 50 nM of enzyme and 50 nM of the substrate in 20mM Tris–HCl, 10 mM KCl, 10 mM (NH4)2SO4, 2 mM MgSO4, 0.1% Triton® X-100 pH 8.8. All the reactions were stopped by adding formamide-loading buffer (6) and heating at 85°C for 3 min. The samples were run in 10–12% urea–PAGE gels and the fluorescence signal was read in a Fusion FX6 EDGE imaging system (Vilber).

The activity of the restriction endonuclease StuI was measured in both phage lambda DNA (New England Biolabs, USA) and a quencher-fluorophore dsDNA probe. Digestions of 250 ng of lambda DNA were performed using 1 mM of the homemade StuI enzymes and 2 units of commercial StuI restriction enzyme (New England Biolabs, USA) for 30 min at 37ºC. The reactions were stopped with 45 mM EDTA and resolved by agarose gel electrophoresis. The quencher-fluorophore dsDNA probe bears a FAM fluorophore and BMN-Q535 quencher at opposite termini (FAM StuI BMN-Q535 quencher + StuI reverse, and FAM Methylated StuI BMN-Q535 quencher + StuI reverse, see Supplementary Table S4). A restriction site for StuI was included in the dsDNA and upon digestion, an increase in fluorescence is expected. The reaction was performed at 37º C in CutSmart buffer (New England Biolabs, USA) in a real-time PCR machine (Rotor-Gene Q, Qiagen, USA), using 1 nM of enzyme and 200 nM of the dsDNA probe. Triplicates of the samples were measured and the background fluorescence was corrected from all samples by subtracting the averaged fluorescence signal of the only dsDNA probe samples. The fluorescence signal was normalized to the highest intensity in the experiment.

Failure-by-design experiments

Using a controlled experimental setup, the goal of these experiments is to show that undesired enzymatic activity during sample handling can be detrimental. The enzymatic concentration, pre-incubation times and conditions were chosen to produce an experimental failure in case of significant exonuclease or polymerase activity during the pre-incubation step. Pre-incubations were carried out always at 25°C to prove that the undesired activity would be present during sample handling as well. The enzymes were light-activated either at the end or at the beginning of the pre-incubation step. Experimental fail is expected in the latter, as the enzymes are active during the pre-incubation. In the case of Phi 29 pol-PC_oligo and Pfu pol-PC_oligo constructs, the failure-by-design experiments aimed at proving decreased amplification yield in case of undesired exonuclease degradation of the primers. For Taq pol-PC_oligo experiments, the primers were deliberately designed to form dimers at their 3′ ends. Polymerase activity would result in elongation during the pre-incubation step, and the elongated primer dimers would eventually compete with the desired PCR product. Pre-Incubation times were set to 2 h, 1 h and 20 min for the case of Phi29, Pfu and Taq pols experiments respectively (optimal incubation times were experimentally determined).

RESULTS

Photoactivatable Phi 29 polymerase

Serendipitously, we observed enzymatic inactivation of the Phi29 pol after binding a DNA oligonucleotide to the enzyme. We covalently attached the oligo to the enzyme using click chemistry (37), incorporating the unnatural amino acid 4-azido-l-phenylalanine (33) in the enzyme and reacting with a DBCO-modified oligonucleotide. As the unnatural amino acid was incorporated in an additional stretch of glycine-serine residues added by us at the c-terminus of the enzyme, we ruled out chemical modification of a key residue during the functionalization as the cause of the inactivation. We reasoned that having one of the natural substrates of the polymerase (ssDNA (38)) attached to it, could produce the effective blockage of the enzyme by means of binding to the protein′s cleft and competing for the accessibility to the active site (either obstructing the access to the active site or directly competing for it). In this case, the inactivation of the enzyme would be reversible, and controlled cleavage of the oligonucleotide would result in enzymatic reactivation (see Figure 1).

Figure 1.

Figure 1.

Schematics of light-start DNA processing enzymes. For illustration purposes, the case of a DNA polymerase is shown. The attachment of the ssDNA to the enzyme hampers the accessibility of the substrate to the active site leading to enzymatic blockage. Only after photocleavage of the bound DNA the activity is restored. The asterisk (*) denotes a photocleavable linker.

In order to test our hypothesis, we included an o-nitrobenzyl-based photocleavable (PC) linker (see experimental section for details) between the first and the second nucleotide proximal to the anchoring point of the enzyme (see Figure 1). In this configuration, a short UV pulse will release the oligonucleotide from the enzyme and reactivate it, giving us control over the activity. In Figure 2A, an SDS-PAGE gel shows the effect of UV pulses of different duration on the light-sensitive enzyme-oligo complex. A band corresponding to unmodified enzyme appeared in the irradiated samples (see lanes 3–5 in Figure 2A), and as expected the proportion of this population correlated positively with the duration of the light pulse. Enzymatic reactivation was tested by multiply-primed rolling circle amplification of plasmid DNA (18). Phi29 pol bound to a regular oligo (Phi29 pol-oligo) and non-irradiated Phi29 pol attached to a PC oligo (Phi29 pol-PC_oligo) showed no detectable activity after two hours of reaction (Figure 2B, lanes 2 and 4), as opposed to unmodified Phi29 pol enzyme, where an intense DNA band was observed in the agarose gel due to DNA polymerization (lane 1). This assures that enzymatic inhibition was also achieved for the PC variant. Furthermore, and more interestingly, the Phi29 pol-PC_oligo samples that were irradiated recovered the enzymatic activity, and this reactivation was correlated with the intensity and duration of the light pulse (Figure 2B, lanes 5–9). This reactivation was not observed in irradiated Phi29 pol_oligo (lane 3), confirming that the reactivation is specific to oligonucleotide cleavage.

We tested two different UV wavelengths to reactivate our enzymes, 315 nm, and the less harmful 365 nm. Efficient enzymatic reactivation was observed for both wavelengths (Figure 2B and C), although shorter pulses seem to be required for the 315 nm wavelength (see Figure 2C, lane 2 versus lane 4). In order to calculate the reactivation efficiency, we first investigated any possible negative effects of the UV light in the reaction (including effects on the template, primers, or enzyme). We studied the effect of both types of UV lights on the unmodified enzyme, as this allows us to decouple the reactivation efficiency from any negative effect caused by UV. We observed that short 10 s pulses with the 315 nm UV light produced a significant reduction of the activity, while 120 s pulses with the 365 nm UV did not have any negative effect on the reaction (see Figure 2D). Therefore, we used the 365 nm to estimate the reactivation efficiency. Under the same experimental conditions, the Phi29 pol-PC_oligo samples recovered the same level of activity as the wild-type enzyme after a 120 s pulse with 365 nm UV light (Figure 2D). Furthermore, we confirmed that the Phi29 pol-PC_oligo enzyme reaches already saturation in the reactivation curve after 120 s (see Figure 2E). Altogether, these results suggest that the enzyme can recover full activity. Besides, we achieved a tight blockage of the enzymatic activity. We did not detect residual activity in the non-illuminated samples, as there was no statistical difference (P < 0.01) with samples that are not able to polymerize (samples without dNTPs, see Figure 2E). Even experiments performed at high concentration of the enzyme (150 nM) did not show activity in the non-illuminated samples (see Supplementary Figure S1a), further confirming a severe inactivation of the enzyme.

In order to confirm that the blockage of enzymatic activity was mediated by unspecific obstruction by the coupled oligo and not by sequence-specific interactions, we used a scrambled version of the blocking oligonucleotide, which has the same nucleobase composition but in a random order (Phi29 pol-PC_oligoScr, see Supporting information for details). This Phi29 pol-PC_oligoScr version also inhibited activity that was recovered with a light pulse (Figure 2F, lanes 1 and 2). Moreover, to rule out any bias caused by the nucleotide composition, we blocked the enzyme with a third oligonucleotide with a completely different sequence (Phi29 pol-PC_oligo2, Supporting information for details). This third type of modified Phi29 pol still displayed the same light-activated behaviour (Figure 2F, lanes 3 and 4).

Blockade of the exonuclease activity

The proposed inhibition mechanism would also provide blockage of the 3′ to 5′ exonuclease (3′-5′ exo) activity of the Phi29 pol, as the oligonucleotide bound to the enzyme might also successfully compete with other exonuclease substrates provided it still hampers the access to the active site. We devised a test to characterize the 3′-5′ exo activity of our Phi29 pol constructs using a 5′ fluorophore-labeled (6-carboxyfluorescein, 6-FAM) single-stranded DNA probe (FAM-labeled ssDNA). Incubation of the labeled oligo with the unmodified Phi29 pol (Figure 3A, lane 2) showed a drastic drop in the intensity of the full-length FAM-labeled ssDNA, and new populations of shortened FAM-labeled ssDNA appeared when compared with the untreated sample (see lane 1 in Figure 3A). This pattern is also observed in the UV-activated Phi29 pol-PC_oligo samples, correlating again the degree of exonucleolitc digestion of the FAM-labeled ssDNA with the duration of the light pulse (Figure 3A, lanes 4 and 5). On the contrary, when the Phi29 pol-PC_oligo sample is not activated by light, the FAM-labeled ssDNA remains intact (Figure 3A, lane 3). Altogether, these results demonstrate the controlled blockage of the 3′-5′ exo activity by the Phi29 pol-PC_oligo. Overall, our data confirm that our approach allows for the blockage and controlled reactivation of a thermolabile DNA polymerase, which is not possible with Hot-start approaches.

Photoactivatable Taq and Pfu DNA polymerases

Our results with the Phi29 pol pointed to unspecific competition-based blockage of the enzyme by the covalently bound oligonucleotide. As the position of the modification was not rationally designed, we hypothesized that the same effect might be observed for other DNA polymerases as long as the oligonucleotide has enough flexibility to reach the active sites. Therefore, we implemented the same strategy in two other DNA polymerases widely used in biotechnology, the Taq and the Pfu DNA polymerases (for a discussion on how exonuclease degradation of the blocking oligo was avoided see Protein-oligo coupling in the Material and Methods section). The Taq pol is the workhorse for PCR applications in all laboratories around the world and Pfu pol is a classical low error rate polymerase for application where high fidelity is desired (10,19,20). As in the case of Phi29 pol, we incorporated 4-azido-l-phenylalanine in an extra stretch of C-terminal GS residues and covalently bound the same light-sensitive oligonucleotide. We first proved the blockage of the polymerization activity by PCR. Figure 3B shows that amplification is only detected in Taq pol-PC_Oligo and Pfu pol-PC_Oligo samples that had been treated with a UV pulse and in wild-type enzymes (see Figure 3B, lanes 1 and 3, left gel for Taq pol and right for Pfu pol, respectively). Non-illuminated samples show no visible DNA band in the agarose gel (lane 2, Figure 3B). Furthermore, we do not have indication that the fidelity of the enzymes is significantly affected by the reactivation approach (see Supplementary Figure S2).

Likewise, we tested for the inhibition of the nuclease activity of these polymerases. The Pfu pol has 3′ to 5′ exo activity, which includes proofreading activity (10,19) (3′ end degradation in double-stranded DNA, dsDNA, with 3′ terminal mismatches). We test the 3′ to 5′ exo activity of the Pfu pol constructs in two types of fluorescently labeled substrates, including ssDNA (FAM-labeled ssDNA) and dsDNA with mismatches (FAM-labeled dsDNA, as a substrate for proofreading activity). In both cases, the Pfu pol-PC_oligo samples that were not photo-activated did not show visible degradation of the substrates (Figure 3C, see lanes 2 and 4, left and right gel for the FAM-labeled ssDNA and FAM-labeled dsDNA substrates, respectively). Only the light-activated samples showed the degradation pattern typical of the wild-type enzymes (see lanes 1 and 3 in Figure 3C for both substrates). Taq DNA pol possesses 5′ nuclease activity, including 5′ to 3′ exonuclease and 5′ flap nuclease activity (10,36). We test the 5′ flap nuclease activity of our samples as it provides a convenient way to detect the 5′ nuclease activity (Figure 3D). Similarly, the nuclease activity of the Taq pol-PC_oligo was inhibited until the samples were photo-activated (Figure 3D, see lanes 3 and 4 and comparison with the wild type enzyme in lane 1). Altogether, our results show that not only the polymerase activity was blocked in the enzymes, but also the nuclease activity.

Generalizing the approach

Our data demonstrated that our approach to block the activity of enzymes works robustly in DNA polymerases. Next, we aimed to check the general applicability of our strategy to other DNA processing enzymes. Specifically, we focus on devising a light-activated version of the StuI Type II restriction enzyme, which is a site-specific endonuclease. Since our approach relies on binding an ssDNA to compete for the access to the active site, the application to StuI would be a very stringent test to our strategy, since StuI is a sequence-specific nuclease acting in dsDNA. Thus, we attached the same oligonucleotide used for the three DNA polymerases to the C-terminus of the StuI enzyme, and checked its activity on two types of substrates. The results, shown in Figure 4, showed an acute inhibition of the nuclease activity of the StuI-PC_oligo samples, which was recovered in the irradiated samples.

Figure 4.

Figure 4.

Selective activation of the restriction enzyme StuI. (A) Digestion of lambda DNA by the StuI restriction enzyme. Efficient digestion of lambda DNA was observed by commercial StuI, unmodified StuI, and irradiated StuI-PC_oligo (lanes 2, 3 and 5, respectively). Interestingly, in the non-photoactivated StuI-PC_oligo sample (lane 4), the lambda DNA stays mostly uncut (see lane 1 for only lambda DNA reference), thus probing effective activation of the StuI-PC_oligo by light. C in lane 2 denotes control digestion and StuI is represented schematically as a scissor. (B) Digestion of a quencher-fluorophore dsDNA probe bearing a StuI restriction site. The irradiated StuI-PC_oligo samples (blue symbols) showed a fast increase of the fluorescence signal, consistent with the efficient digestion of the probe. This behaviour was largely suppressed in non-illuminated samples (red symbols), where just a mild increase in the fluorescence is observed when compared with dsDNA probe alone (black symbols). The observed digestion was sequence-specific, as the digestion of a dsDNA probe methylated in the restriction site (green symbols, see Supplementary Table S4) by the activated StuI_oligo was abolished. A light pulse of 120 s with 365nm wavelength UV light was used for both types of experiments.

Digestion of phage lambda DNA by photoactivated StuI-PC_oligo revealed the same electrophoretic DNA pattern as the unmodified and commercial enzymes (see Figure 4A, lanes 2, 3 and 5 for the commercial, unmodified, and irradiated StuI-PC_oligo enzymes, respectively). This underlines that the StuI-PC_oligo version kept the sequence specificity of the wild type enzyme and was able of efficient substrate digestion comparable to the unmodified enzyme. Interestingly, this behaviour was largely abrogated in the non-illuminated StuI-PC_oligo sample (lane 4 in Figure 4A), which displayed only residual digestion of the lambda DNA (see lane1 in Figure 4A for a reference of undigested DNA). The digestion of the second type of substrate, a quencher-fluorophore dsDNA bearing a StuI restriction site, showed consistent results (see blue symbols vs red symbols in Figure 4B for illuminated and non-illuminated samples respectively). Furthermore, a dsDNA probe methylated in the restriction site and protected by a phosphorothioate modification (green symbols in Figure 4B, see Supplementary Table S4 for details) showed abolished digestion. These results indicate the selective digestion of the StuI restriction site and exclude contamination of endonucleases during the recombinant production of the protein. Although the inhibition of the activity seems not to be as acute as in the case of the DNA polymerases, there is a remarkable blockage of the enzymatic activity, especially considering that we could not manage to purify oligo-modified enzyme free of unmodified protein (see the significant amount of unmodified StuI enzyme in gel in Supplementary Figure S3). Canonical type II restriction enzymes are dimeric (39) and we interpreted the constant co-elution of both species after several chromatographic purification steps as hybrid dimers. This could explain the severe inhibition achieved, as the unmodified enzyme might still be forming hybrid oligomers with oligo-bearing ones. Our results suggest that even though dsDNA is the canonical substrate for restriction enzymes, the enzyme may retain substantial binding affinity to single-stranded DNA, which mediates the blockage. Alternatively, steric hindrance by the oligonucleotide bound to the enzyme could also render the observed inhibition. Overall, our data showed substantial photoactivation of the StuI-PC_oligo enzyme and efficient recovery of the activity, comparable to that of the unmodified enzyme. Nevertheless, the inaccuracy in the estimation of the concentration of the StuI-PC_oligo associated with the sample′s heterogeneity hampered a more quantitative assessment of the reactivation.

Altogether, our data suggest that the presented approach for controlled activation of DNA processing enzymes is of broad applicability and potentially transferable to many other enzymes

Application of the light-activatable enzymes to classical biotechnological methods

Finally, as proof of the relevance of our approach, we tested the applicability of our light-start DNA polymerases to common molecular biology applications. We designed a series of failure-by-design experiments, typically used to prove the goodness of hot-start approaches (13). The samples were pre-incubated before the assay and the experiment was designed in a way that undesired enzymatic activity during the pre-incubation would lead to detrimental effects on the assay. (14,40). Specifically, samples were light-started at the beginning or the end of the pre-incubation and the negative effect was expected in the former, as the enzyme is active during the incubation.

Primer and template degradation by exonuclease activity is an issue in Phi29 pol and Pfu pol applications, producing decreased amplification yield in both cases and promoting unspecific off-target amplification in Pfu pol PCRs (10,18,19,30). We performed whole human genome amplification (29) using the Phi pol-PC_oligo enzyme to test for exonuclease protection. We observed a severe reduction of the product yield in the samples activated at the start of the incubation step (see comparison with post-incubation activation, Figure 5A, and Supplementary Figure S1b). The same bias was observed for Pfu pol-PC_oligo, when we performed a PCR to amplify the Biotin ligase gene (bir A) from E. coli chromosomal DNA (Figure 5B and Supplementary Figure S1c). These results are compatible with exonuclease degradation of the primers during the incubation and show the protection provided by our light-start enzymes.

In the case of Taq pol, elongation of misprimed primer during sample handling can lead to a loss of specificity in PCR (9,20). We PCR-amplified a 258 base pairs (bp) fragment of E. coli′s bir A gene and faulty designed the forward and reverse primers to anneal between their 3′ ends. These primer dimers if elongated during the incubation would compete with the PCR fragment. We observed that, while Taq pol-PC_oligo samples that were activated after the incubation showed a robust amplification of the 258 bp fragment, in the samples photo-activated before the incubation the primers dimers competed with the desired fragment and produced an acute reduction in the PCR yield (see Figure 5C, lanes 1, 4 and 5, and Supplementary Figure S1d). Furthermore, similar behaviour was observed using a commercial hot-start Taq polymerase based on aptamer blockage (Figure 5C, lanes 2 and 3).

Overall, we have proven that light-start polymerases are a robust alternative to traditional hot-start approaches. Unlike the latter, our approach can be generalized to thermolabile enzymes and we have shown that, unlike previous strategies (9,12,16,20,41), it is straightforward to implement and potentially applicable to diverse DNA polymerases.

DISCUSSION

A light-activatable version of the Taq DNA polymerase has been previously reported, but only partial recovery of the enzymatic activity was shown. In this previous work, the polymerization activity of the enzyme was impeded by sterically blocking the space reserved for the incoming dNTPs (12). Although very elegant, the experimental design of the photoactivatable enzyme was therefore not expected to affect the flap endonuclease activity of the enzyme. In addition, this example highlights one of the main advantages of our approach, as we did not require the structural and mechanistic information to develop the photoactivatable enzyme. This is particularly important in the case of our light-activatable StuI restriction endonuclease. Photoactivatable BamHI, PvuII, and MunI restriction enzymes have been developed in the past by modifying residues of the active site or key residues involved in the dimerization of the proteins (24,26,42). This would have been extremely challenging in the case of the presented StuI enzyme as, to the best of our knowledge, there is no known structure of the enzyme deposited in Protein Data Bank (https://www.rcsb.org/).

The application of the presented methodology to four different DNA processing enzymes, with diverse type of enzymatic activity, including DNA polymerase, exonuclease (5′-3′ and 3′-5′ exonuclease) and endonuclease activity shows promise as a general method to control the activity of these enzymes. In addition, producing the light-activatable version of the enzymes proves to be straightforward, as it sufficed to bind the photocleavable oligonucleotide in an extra stretch of aminoacids at the c-teminus of the enzyme. The latter is of particular practical interest because no specific design or knowledge of the enzymes needs to be taken into account. We are confident that this approach offers an alternative option before engaging in more complex and demanding strategies. Furthermore, the strategy would be potentially transferable to enzymes with strict dependence on dsDNA, by means of including a stem–loop structure in the blocking oligo.

DATA AVAILABILITY

All data and materials are available from the corresponding authors on request.

Supplementary Material

gkab1212_Supplemental_File

Contributor Information

Merve-Zeynep Kesici, Department of Chemistry and Center for NanoScience, Ludwig-Maximilians-Universität München, München 81377, Germany.

Philip Tinnefeld, Department of Chemistry and Center for NanoScience, Ludwig-Maximilians-Universität München, München 81377, Germany.

Andrés Manuel Vera, Department of Chemistry and Center for NanoScience, Ludwig-Maximilians-Universität München, München 81377, Germany.

SUPPLEMENTARY DATA

Supplementary Data are available at NAR Online.

FUNDING

European Union's Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie [746635]; German Federal Ministry of Education and Research [POCEMON, 13N14336]. Funding for open access charge: Budget from the chair of Physical Chemistry.

Conflict of interest statement. P.T. and A.M.V. are co-inventors of an European patent application (EP21194389.9) covering the results contained in this article.

REFERENCES

  • 1. Ran F.A., Hsu P.D., Wright J., Agarwala V., Scott D.A., Zhang F.. Genome engineering using the CRISPR-Cas9 system. Nat. Protoc. 2013; 8:2281–2308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Aschenbrenner J., Marx A.. DNA polymerases and biotechnological applications. Curr. Opin. Biotechnol. 2017; 48:187–195. [DOI] [PubMed] [Google Scholar]
  • 3. Kaminski M.M., Abudayyeh O.O., Gootenberg J.S., Zhang F., Collins J.J.. CRISPR-based diagnostics. Nat. Biomed. Eng. 2021; 5:643–656. [DOI] [PubMed] [Google Scholar]
  • 4. Ouaray Z., Benner S.A., Georgiadis M.M., Richards N.G.J.. Building better polymerases: engineering the replication of expanded genetic alphabets. J. Biol. Chem. 2020; 295:17046–17059. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Gu L., Yan W., Liu L., Wang S., Zhang X., Lyu M.. Research progress on rolling circle amplification (RCA)-based biomedical sensing. Pharmaceuticals. 2018; 11:35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Sambrook J. Molecular Cloning: A Laboratory Manual. 2001; 3rd ednNY: Cold Spring Harbor Laboratory Press. [Google Scholar]
  • 7. Ankenbruck N., Courtney T., Naro Y., Deiters A.. Optochemical control of biological processes in cells and animals. Angew. Chem. Int. Ed. 2018; 57:2768–2798. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Han T., Chen Q., Liu H.. Engineered photoactivatable genetic switches based on the bacterium phage T7 RNA polymerase. ACS Synth. Biol. 2017; 6:357–366. [DOI] [PubMed] [Google Scholar]
  • 9. Rutschke N., Zimmermann J., Möller R., Klöck G., Winterhalter M., Leune A.. Hot start reverse transcriptase: an approach for improved real-time RT-PCR performance. J. Anal. Sci. Technol. 2015; 6:20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Terpe K. Overview of thermostable DNA polymerases for classical PCR applications: from molecular and biochemical fundamentals to commercial systems. Appl. Microbiol. Biotechnol. 2013; 97:10243–10254. [DOI] [PubMed] [Google Scholar]
  • 11. Paul N., Shum J., Le T.. Hot start PCR. Methods Mol. Biol. 2010; 630:301–318. [DOI] [PubMed] [Google Scholar]
  • 12. Chou C., Young D.D., Deiters A.. A light-activated DNA polymerase. Angew. Chem. Int. Ed. 2009; 48:5950–5953. [DOI] [PubMed] [Google Scholar]
  • 13. Lebedev A.V., Paul N., Yee J., Timoshchuk V.A., Shum J., Miyagi K., Kellum J., Hogrefe R.I., Zon G.. Hot Start PCR with heat-activatable primers: a novel approach for improved PCR performance. Nucleic. Acids. Res. 2008; 36:e131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Kermekchiev M.B., Tzekov A., Barnes W.M.. Cold-sensitive mutants of Taq DNA polymerase provide a hot start for PCR. Nucleic Acids Res. 2003; 31:6139–6147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Lin Y., Jayasena S.D.. Inhibition of multiple thermostable DNA polymerases by a heterodimeric aptamer. J. Mol. Biol. 1997; 271:100–111. [DOI] [PubMed] [Google Scholar]
  • 16. Kellogg D.E., Rybalkin I., Chen S., Mukhamedova N., Vlasik T., Siebert P.D., Chenchik A.. TaqStart antibody: “hot start” PCR facilitated by a neutralizing monoclonal antibody directed against Taq DNA polymerase. BioTechniques. 1994; 16:1134–1137. [PubMed] [Google Scholar]
  • 17. Gardner A.F., Kelman Z.. DNA polymerases in biotechnology. Front. microbiol. 2014; 5:659. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Dean F.B., Nelson J.R., Giesler T.L., Lasken R.S.. Rapid amplification of plasmid and phage DNA using Phi 29 DNA polymerase and multiply-primed rolling circle amplification. Genome Res. 2001; 11:1095–1099. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Skerra A. Phosphorothioate primers improve the amplification of DNA sequences by DNA polymerases with proofreading activity. Nucleic Acids Res. 1992; 20:3551–3554. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Noma T., Sode K., Ikebukuro K.. Characterization and application of aptamers for Taq DNA polymerase selected using an evolution-mimicking algorithm. Biotechnol. Lett. 2006; 28:1939–1944. [DOI] [PubMed] [Google Scholar]
  • 21. Edwards W.F., Young D.D., Deiters A.. Light-Activated cre recombinase as a tool for the spatial and temporal control of gene function in mammalian cells. ACS Chem. Biol. 2009; 4:441–445. [DOI] [PubMed] [Google Scholar]
  • 22. Chou C., Deiters A.. Light-activated gene editing with a photocaged zinc-finger nuclease. Angew. Chem. Int. Ed. 2011; 50:6839–6842. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Nihongaki Y., Kawano F., Nakajima T., Sato M.. Photoactivatable CRISPR-Cas9 for optogenetic genome editing. Nat. Biotechnol. 2015; 33:755–760. [DOI] [PubMed] [Google Scholar]
  • 24. Silanskas A., Foss M., Wende W., Urbanke C., Lagunavicius A., Pingoud A., Siksnys V.. Photocaged variants of the MunI and PvuII restriction enzymes. Biochemistry. 2011; 50:2800–2807. [DOI] [PubMed] [Google Scholar]
  • 25. Pingoud A., Silva G.H.. Precision genome surgery. Nat. Biotechnol. 2007; 25:743–744. [DOI] [PubMed] [Google Scholar]
  • 26. Schierling B., Noël A.-J., Wende W., Hien L.T., Volkov E., Kubareva E., Oretskaya T., Kokkinidis M., Römpp A., Spengler B.et al.. Controlling the enzymatic activity of a restriction enzyme by light. Proc. Natl. Acad. Sci. U.S.A. 2010; 107:1361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Andersen E.S., Dong M., Nielsen M.M., Jahn K., Subramani R., Mamdouh W., Golas M.M., Sander B., Stark H., Oliveira C.L.P.et al.. Self-assembly of a nanoscale DNA box with a controllable lid. Nature. 2009; 459:73–76. [DOI] [PubMed] [Google Scholar]
  • 28. Bruetzel L.K., Gerling T., Sedlak S.M., Walker P.U., Zheng W., Dietz H., Lipfert J.. Conformational changes and flexibility of DNA devices observed by Small-Angle X-ray scattering. Nano Lett. 2016; 16:4871–4879. [DOI] [PubMed] [Google Scholar]
  • 29. Nelson J.R. Random-primed, Phi29 DNA polymerase-based whole genome amplification. Curr. Protoc. Mol. Biol. 2014; 105:15.13.1–15.13.16. [DOI] [PubMed] [Google Scholar]
  • 30. Silander K., Saarela J.. Whole genome amplification with Phi29 DNA polymerase to enable genetic or genomic analysis of samples of low DNA yield. Methods Mol. Biol. 2008; 439:1–18. [DOI] [PubMed] [Google Scholar]
  • 31. Ali M.M., Li F., Zhang Z., Zhang K., Kang D.K., Ankrum J.A., Le X.C., Zhao W.. Rolling circle amplification: a versatile tool for chemical biology, materials science and medicine. Chem. Soc. Rev. 2014; 43:3324–3341. [DOI] [PubMed] [Google Scholar]
  • 32. Hemphill J., Borchardt E.K., Brown K., Asokan A., Deiters A.. Optical control of CRISPR/Cas9 gene editing. J. Am. Chem. Soc. 2015; 137:5642–5645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Chin J.W., Santoro S.W., Martin A.B., King D.S., Wang L., Schultz P.G.. Addition of p-Azido-l-phenylalanine to the Genetic Code of Escherichia coli. J. Am. Chem. Soc. 2002; 124:9026–9027. [DOI] [PubMed] [Google Scholar]
  • 34. de Vega M., Lazaro J.M., Salas M., Blanco L.. Primer-terminus stabilization at the 3′-5′ exonuclease active site of phi29 DNA polymerase. Involvement of two amino acid residues highly conserved in proofreading DNA polymerases. EMBO J. 1996; 15:1182–1192. [PMC free article] [PubMed] [Google Scholar]
  • 35. Vera A.M., Galera-Prat A., Wojciechowski M., Różycki B., Laurents D.V., Carrión-Vázquez M., Cieplak M., Tinnefeld P.. Cohesin-dockerin code in cellulosomal dual binding modes and its allosteric regulation by proline isomerization. Structure. 2021; 29:587–597. [DOI] [PubMed] [Google Scholar]
  • 36. Lyamichev V., Brow M.A., Dahlberg J.E.. Structure-specific endonucleolytic cleavage of nucleic acids by eubacterial DNA polymerases. Science. 1993; 260:778. [DOI] [PubMed] [Google Scholar]
  • 37. Fantoni N.Z., El-Sagheer A.H., Brown T.. A hitchhiker's guide to Click-Chemistry with nucleic acids. Chem. Rev. 2021; 121:7122–7154. [DOI] [PubMed] [Google Scholar]
  • 38. Garmendia C., Bernad A., Esteban J.A., Blanco L., Salas M.. The bacteriophage phi 29 DNA polymerase, a proofreading enzyme. J. Biol. Chem. 1992; 267:2594–2599. [PubMed] [Google Scholar]
  • 39. Pingoud A., Jeltsch A.. Structure and function of type II restriction endonucleases. Nucleic Acids Res. 2001; 29:3705–3727. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. Kubu C.J. HotStart-IT®: a novel hot start PCR method based on primer sequestration. BioTechniques. 2008; 44:275–277. [Google Scholar]
  • 41. Pan X., Urban A.E., Palejev D., Schulz V., Grubert F., Hu Y., Snyder M., Weissman S.M.. A procedure for highly specific, sensitive, and unbiased whole-genome amplification. Proc. Natl. Acad. Sci. U.S.A. 2008; 105:15499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42. Endo M., Nakayama K., Majima T.. Design and synthesis of photochemically controllable restriction endonuclease BamHI by manipulating the salt-bridge network in the dimer interface. J. Org. Chem. 2004; 69:4292–4298. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

gkab1212_Supplemental_File

Data Availability Statement

All data and materials are available from the corresponding authors on request.


Articles from Nucleic Acids Research are provided here courtesy of Oxford University Press

RESOURCES